Cellectar Biosciences Inc (CLRB)
2.03
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
2.035
0.00 (0.00%)
After-Hours: 20:00
Cellectar Biosciences Market Cap: 82.35M for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 82.35M |
| November 01, 2024 | 82.35M |
| October 31, 2024 | 82.76M |
| October 30, 2024 | 83.16M |
| October 29, 2024 | 83.16M |
| October 28, 2024 | 83.16M |
| October 25, 2024 | 82.35M |
| October 24, 2024 | 75.28M |
| October 23, 2024 | 73.13M |
| October 22, 2024 | 76.00M |
| October 21, 2024 | 75.64M |
| October 18, 2024 | 74.92M |
| October 17, 2024 | 73.85M |
| October 16, 2024 | 74.57M |
| October 15, 2024 | 73.13M |
| October 14, 2024 | 74.57M |
| October 11, 2024 | 76.00M |
| October 10, 2024 | 75.28M |
| October 09, 2024 | 73.13M |
| October 08, 2024 | 76.36M |
| October 07, 2024 | 76.72M |
| October 04, 2024 | 78.87M |
| October 03, 2024 | 77.43M |
| October 02, 2024 | 77.43M |
| October 01, 2024 | 74.57M |
| Date | Value |
|---|---|
| September 30, 2024 | 76.72M |
| September 27, 2024 | 73.13M |
| September 26, 2024 | 68.47M |
| September 25, 2024 | 68.83M |
| September 24, 2024 | 71.70M |
| September 23, 2024 | 71.34M |
| September 20, 2024 | 74.21M |
| September 19, 2024 | 75.64M |
| September 18, 2024 | 75.28M |
| September 17, 2024 | 75.64M |
| September 16, 2024 | 74.57M |
| September 13, 2024 | 76.36M |
| September 12, 2024 | 75.64M |
| September 11, 2024 | 74.92M |
| September 10, 2024 | 76.00M |
| September 09, 2024 | 76.36M |
| September 06, 2024 | 74.57M |
| September 05, 2024 | 75.28M |
| September 04, 2024 | 76.72M |
| September 03, 2024 | 76.72M |
| August 30, 2024 | 78.87M |
| August 29, 2024 | 78.51M |
| August 28, 2024 | 78.87M |
| August 27, 2024 | 78.87M |
| August 26, 2024 | 77.79M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
9.678M
Minimum
Jun 03 2020
132.33M
Maximum
Apr 02 2024
44.73M
Average
32.48M
Median
Aug 20 2020
Market Cap Benchmarks
| Perspective Therapeutics Inc | 821.94M |
| Actinium Pharmaceuticals Inc | 54.83M |
| Chimerix Inc | 88.74M |
| Marinus Pharmaceuticals Inc | 18.46M |
| Jaguar Health Inc | 9.610M |
Market Cap Related Metrics
| Price to Book Value | 18.15 |
| Price | 2.03 |
| Earnings Yield | -152.2% |